ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
Clinical trial NCT04891198 · RECRUITING
Trial details
- NCT number
- NCT04891198
- Sponsor
- 3D Medicines (Sichuan) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2027-08-30
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.